Kilitch Drugs (India) Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|
| Revenue | 45.42 | 37.62 | 58.63 |
| Operating Expense | 34.14 | 30.55 | 42.40 |
| Net Profit | 8.72 | 4.79 | 11.37 |
| Net Profit Margin | 19.20 | 12.73 | 19.39 |
| Earning Per Share | 5.27 | 2.98 | 7.07 |
| EBIDTA | 11.71 | 7.18 | 16.16 |
| Effective Tax Rate | 15.78 | 18.39 | 21.93 |
| Particulars | Sep 2025 |
|---|---|
| Revenue | 45.42 |
| Operating Expense | 34.14 |
| Net Profit | 8.72 |
| Net Profit Margin | 19.20 |
| Earning Per Share | 5.27 |
| EBIDTA | 11.71 |
| Effective Tax Rate | 15.78 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 181.59 | 131.60 | 117.78 |
| Operating Expenses Annual | 150.75 | 111.28 | 100.61 |
| Operating Profit Annual | 44.55 | 26.51 | 21.77 |
| Interest Annual | 2.13 | 1.91 | 0.99 |
| Depreciation | 1.74 | 1.24 | 1.34 |
| Net Profit Annual | 31.16 | 17.57 | 15.72 |
| Tax Annual | 9.53 | 5.78 | 3.73 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 181.59 |
| Operating Expenses Annual | 150.75 |
| Operating Profit Annual | 44.55 |
| Interest Annual | 2.13 |
| Depreciation | 1.74 |
| Net Profit Annual | 31.16 |
| Tax Annual | 9.53 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 17.95 | 17.84 | 2.45 |
| Cash Flow from Operations | 15.23 | -2.58 | 6.10 |
| Cash Flow from Investing | -41.42 | -8.71 | 6.24 |
| Cash Flow from Financing | 15.65 | 11.40 | 3.04 |
| Cash Flow at the End | 7.41 | 17.95 | 17.84 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 17.95 |
| Cash Flow from Operations | 15.23 |
| Cash Flow from Investing | -41.42 |
| Cash Flow from Financing | 15.65 |
| Cash Flow at the End | 7.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 21.10 | 20.23 | 18.63 |
| PBIT Margin (%) | 20.14 | 19.29 | 17.49 |
| PBT Margin (%) | 11.75 | 9.75 | 2.28 |
| Net PROFIT Margin (%) | 17.16 | 13.35 | 13.35 |
| Return On Networth / Equity (%) | 11.02 | 8.39 | 8.41 |
| Return On Networth /Employed (%) | 13.14 | 10.74 | 9.89 |
| Return On Assets (%) | 11.15 | 7.48 | 7.61 |
| Total Debt / Equity (X) | 0.17 | 0.13 | 0.11 |
| Asset Turnover Ratio (%) | 0.65 | 0.56 | 0.57 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 21.10 |
| PBIT Margin (%) | 20.14 |
| PBT Margin (%) | 11.75 |
| Net PROFIT Margin (%) | 17.16 |
| Return On Networth / Equity (%) | 11.02 |
| Return On Networth /Employed (%) | 13.14 |
| Return On Assets (%) | 11.15 |
| Total Debt / Equity (X) | 0.17 |
| Asset Turnover Ratio (%) | 0.65 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 19.51 | 15.70 | 15.08 |
| Total Current Assets Annual | 162.38 | 141.49 | 114.77 |
| Non Current Assets Annual | 195.78 | 145.98 | 137.65 |
| Total Shareholders Funds Annual | 252.94 | 222.92 | 195.93 |
| Total Assets Annual | 358.16 | 287.47 | 252.42 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 19.51 |
| Total Current Assets Annual | 162.38 |
| Non Current Assets Annual | 195.78 |
| Total Shareholders Funds Annual | 252.94 |
| Total Assets Annual | 358.16 |
EPS (INR)
Expected
4.69
Reported
4.97
Surprise
5.97%
Jun 2025
EPS beaten by 5.97%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
